16 The impact of implanting ctDNA testing on day 0 of the lung cancer pathway in patients with advanced stage disease in Manchester

Circulating tumour DNA (ctDNA) can be detected in peripheral blood of cancer patients and tested for genomic alterations and could support the delivery of the Lung Cancer Optimal Pathway (LCOP).

Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Avik Ghoshal, Patrick Goodley, Gaurav Ahuja, Heshani De Silva, Alaa Alsaaty, Charlotte Watson, Richard Booton, Haval Balata, Phil Crosbie, Nicola Sinnott, Jonathan Hiu Nian Chung, Christopher Craig, Matthew Krebs, Anthony Sutcliffe, Matthew Evison Tags: Clinical Networks and Pathways Source Type: research